Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Lung Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00899782
What this trial is testing

Collection and Storage of Blood and Tissue Samples From Patients Who Are Undergoing Surgery For Lung Cancer

Who this might be right for
Lung CarcinomaLung NeoplasmMalignant Lung Neoplasm
Alliance for Clinical Trials in Oncology 500
Testing effectiveness (Phase 2)Study completedNCT05795595
What this trial is testing

A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors

Who this might be right for
Clear Cell Renal Cell CarcinomaCervical CarcinomaEsophageal Carcinoma+2 more
CRISPR Therapeutics AG 19
Testing effectiveness (Phase 2)Study completedNCT00365053
What this trial is testing

PXD101 as Second-Line Therapy in Treating Patients With Malignant Mesothelioma of the Chest That Cannot Be Removed By Surgery

Who this might be right for
Advanced Malignant MesotheliomaEpithelial MesotheliomaRecurrent Malignant Mesothelioma+1 more
National Cancer Institute (NCI) 13
Not applicableLooking for participantsNCT06959719
What this trial is testing

ARMSTRONG - Air entRainMent vS sTandard tReatment in nOn-expandable luNG

Who this might be right for
Non-expandable LungTrapped LungPleural Effusion+1 more
Cambridge University Hospitals NHS Foundation Trust 41
Not applicableActive Not RecruitingNCT07262671
What this trial is testing

Predictive Value of Exosomes in Pleural Effusion for Advanced Lung Cancer

Who this might be right for
NSCLC (Advanced Non-small Cell Lung Cancer)
Fudan University 100
Testing effectiveness (Phase 2)UnknownNCT04369872
What this trial is testing

Microwave Ablation of Primary and Secondary Lung Malignancies

Who this might be right for
Lung NeoplasmsNeoplasm Metastasis
University of Calgary 35
Not applicableStudy completedNCT02214134
What this trial is testing

SPECTAlung: Screening Patients With Thoracic Tumors for Efficient Clinical Trial Access

Who this might be right for
Any Stage of Lung Cancer (Any Histotype)Any Stage of Malignant Pleural MesotheliomaAny Stage of Any Thymic Malignancy
European Organisation for Research and Treatment of Cancer - EORTC 539
Large-scale testing (Phase 3)UnknownNCT01977209
What this trial is testing

Gossypol Combined With Docetaxel and Cisplatin Scheme in Advanced Non Small-cell Lung Cancers With APE1 High Expression

Who this might be right for
Non-small Cell Lung Cancer
Third Military Medical University 204
Not applicableLooking for participantsNCT07552467
What this trial is testing

Sub-topic Four: Clinical Translation of Original Radioactive Drugs for Precision Diagnosis and Treatment of Gastrointestinal Tumors -Clinical Application Value of PET Imaging Targeting LRRC15 in Malignant Tumors

Who this might be right for
Pancreatic CancerBreast CancerLung Cancer+5 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 26
Early research (Phase 1)Study completedNCT00020267
What this trial is testing

Vaccine Therapy in Treating Patients With Metastatic Cancer

Who this might be right for
Lung CancerAdult Soft Tissue SarcomaColorectal Cancer+8 more
National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT05861947
What this trial is testing

Clinical Trial of AUR106 in Patients With Relapsed Advanced Malignancies

Who this might be right for
RelapseAdvanced Malignant NeoplasmNon Small Cell Lung Cancer+5 more
Aurigene Discovery Technologies Limited 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04225117
What this trial is testing

Evaluate Enfortumab Vedotin in Subjects With Locally Advanced or Metastatic Malignant Solid Tumors (EV-202)

Who this might be right for
Locally Advanced or Metastatic Malignant Solid Tumors
Astellas Pharma Global Development, Inc. 329
Testing effectiveness (Phase 2)Study completedNCT02054052
What this trial is testing

Intrapleural Bevacizumab Injection for Malignant Effusion in Lung Cancer

Who this might be right for
Non-small Cell Lung CancerMalignant Pleural Effusion
Haihong Yang, MD, Pricipal investigator 22
Testing effectiveness (Phase 2)Study completedNCT00053885
What this trial is testing

PTK787/ZK 222584 in Treating Patients With Unresectable Malignant Mesothelioma

Who this might be right for
Malignant Mesothelioma
Alliance for Clinical Trials in Oncology 47
Testing effectiveness (Phase 2)Study completedNCT00003989
What this trial is testing

ISIS 3521 in Treating Patients With Advanced, Unresectable, or Metastatic Non-small Cell Lung Cancer or Unresectable or Metastatic Melanoma

Who this might be right for
Lung CancerMelanoma (Skin)
European Organisation for Research and Treatment of Cancer - EORTC 50
Testing effectiveness (Phase 2)Study completedNCT00564733
What this trial is testing

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Who this might be right for
Malignant Pleural EffusionStage IIIB Non-small Cell Lung CancerStage IV Non-small Cell Lung Cancer
University of Washington 55
Not applicableStudy completedNCT06955468
What this trial is testing

Evaluating a Bidirectional Priming Intervention for Goals-of-care Communication in Oncology

Who this might be right for
Lung CancersGastrointestinal Cancers
Abramson Cancer Center at Penn Medicine 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT03213652
What this trial is testing

Ensartinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With ALK or ROS1 Genomic Alterations (A Pediatric MATCH Treatment Trial)

Who this might be right for
Advanced Malignant Solid NeoplasmMalignant Solid NeoplasmRecurrent Ependymoma+30 more
National Cancer Institute (NCI) 13
Very early researchStudy completedNCT01722149
What this trial is testing

Re-directed T Cells for the Treatment (FAP)-Positive Malignant Pleural Mesothelioma

Who this might be right for
Malignant Pleural Mesothelioma
University of Zurich 4
Not applicableWithdrawnNCT00897143
What this trial is testing

Identifying Early Lung Cancer Cells in Malignant Pleural Effusion Samples From Patients With Primary Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Case Comprehensive Cancer Center
Next Page